Hypertensive nephropathy epidemiology and demographics

Jump to navigation Jump to search

Hypertensive nephropathy Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Differentiating Hypertensive Nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Abdominal X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertensive nephropathy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypertensive nephropathy epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertensive nephropathy epidemiology and demographics

CDC on Hypertensive nephropathy epidemiology and demographics

Hypertensive nephropathy epidemiology and demographics in the news

Blogs on Hypertensive nephropathy epidemiology and demographics

Directions to Hospitals Treating Hypertensive nephropathy

Risk calculators and risk factors for Hypertensive nephropathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]Nasrin Nikravangolsefid, MD-MPH [3]

Overview

The incident counts and adjusted rates for hypertensive renal disease has been increasing gradually over the past three decades. 25,000 new cases of chronic renal failure attributable to high blood pressure, are diagnosed every year in the US. It has also contributed significantly to the increase in the number of patients undergoing dialysis from renal insufficiency.

Epidemiology and Demographics

Prevalence

  • More than 20% of patients with systemic hypertension have chronic renal insufficiency.
  • The prevalence of hypertensive nephropathy among those with hypertension is 24.6%.
  • According to USRDS annual data report"USRDS"., the overall prevalence of CKD among patients aged greater than 65 years in 2017 was 14.5% (186,997 from 1,291,640), however in the hypertensive population aged 65+ years was 16.3%.
  • Incidence of hemodialysis, peritoneal dialysis, and transplantation among CKD due to hypertension in the US population was reported 35,843 from 124,369 in 2017. Whereas, the prevalence of these therapeutic modalities was 192,907 from 743,624.


Age

  • Hypertensive renal disease has a higher prevalence in those aged 65 years and older.
  • The prevalence of CKD due to hypertension increased with age from 11.7% at ages 65–74 to 25.5% at age≥ 85.


Race

  • The prevalence of hypertensive nephropathy is higher in African Americans.

External Links

References

Template:WH Template:WS